USPTO serial 86442693
OSE PHARMA
Reviewed by CopyMark Law Group
Reg. 4776010Status 710
- Filing date
- Status date
- Registration date
- Jul 21, 2015
- Examiner
- PRICE, WANDA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with OSE PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
44200 Nantes, FR
Orphan Synergy Europe - Pharma
Paris, FR
Orphan Synergy Europe - Pharma
Paris, FR
Orphan Synergy Europe - Pharma
Paris, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Jennings
PATRICK J. JENNINGS PILLSBURY WINTHROP SHAW PITTMAN LLP1200 Seventeenth Street, NWWashington, DC 20036-3006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for cancer treatment, oncology and immunotherapy; Sanitary preparations for medical use; Pharmaceutical products for use in human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment, oncology and immunotherapy; Vaccines; Medicated serums for cancer treatment, oncology and immunotherapy; Chemical reagents for medical purposes; All-purpose disinfectants | SECTION 8 - CANCELLED | — |
| 042 | Scientific research; Research in the fields of medicine and pharmaceuticals; Design and development of computer software and computer databases; Medical research; Biological and biotechnology research; Pharmaceutical research services; Scientific study and research in the fields of health and medicine | SECTION 8 - CANCELLED | — |
| 044 | Medical services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OSE IMMUNOTHERAPEUTICS
- Other trademarks owned by Orphan Synergy Europe - Pharma
- Other trademarks owned by Orphan Synergy Europe - Pharma
- Other trademarks owned by Orphan Synergy Europe - Pharma
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named OSE PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 28, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 21, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 20, 2016 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 20, 2016 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 3, 2016 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 21, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 5, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 25, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2015 | ALIE | ASSIGNED TO LIE | — |
| Mar 12, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 13, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 15, 2014 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Nov 13, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 6, 2014 | NWAP | NEW APPLICATION ENTERED | — |